Robotic Angiography Systems Market

Robotic Angiography Systems Market Outlook

The global robotic angiography systems market is expected to expand at a healthy CAGR of nearly 5% to 6% during the forecast period 2022-2032. The adoption of advanced diagnostics equipments and innovative imaging tools is rapidly increasing across the medical sector, for high precision, accurate, and reliable assessment of the blood flow-related complications inside the human body. This is estimated to create high revenue generation opportunities in the robotic angiography systems market.

Report Attribute	Details
Robotic Angiography Systems Market Projected Growth Rate (2022-2032)	5% to 6% CAGR

Angiography is a type of minimally invasive medical imaging technique used to view the insides of distinct organs and blood vessels in the human body. With increasing advancements in imaging technology and growing integration of automation, healthcare infrastructures are increasing adoption of novel robotic imaging solutions for angiography. This is projected to augment the demand for robotic angiography systems in the global market.

Which are Some Prominent Drivers Spearheading Robotic Angiography Systems Market Growth?

Due to increasing obesity, growing bad eating habits, and rising consumption of alcohol, there is a significant rise in the burden of heart and kidney-related disorders across the globe. For instance, according to a study by the National Institute of Diabetes and Digestive and Kidney Diseases, nearly 37 million people, or more than 1 out of 7 adults in the U.S. are reported to be suffering from chronic kidney diseases.

Robotic angiography systems are increasingly used for visualizing the blood vessels in the heart and kidneys for the accurate identification and assessment of the complications, by declining the risk of human errors. Hence, growing burden of such diseases is anticipated to drive the sales in the global market.

What are the Key Constraints Faced by the Robotic Angiography Systems Market?

Although there are numerous benefits associated with the use of robotic angiography systems, some of the factors such as high risk of radiation exposure, injury due to catheterized artery, and unsuitability for critically ill patients among others are hampering the sales in the global market.

Also, high cost of the angiography procedures, extravagant initial cost of robotic angiography systems, and limited reimbursement for angiographic surgeries are further impeding the growth in the market.

Why is North America Emerging as an Opportunistic Robotic Angiography Systems Market?

North America is forecast to emerge as the most lucrative market for robotic angiography systems between 2022 and 2032, as per a study by FMI.

As the burden of conditions related to blood vessels, brain, heart, kidney, and others continues to increase along with growing adoption of high precision imaging solutions, there is a rise in demand for robotic angiography systems. Hence, leading manufacturers are focusing on launching new products to address the growing demand.

For instance, in 2021, GE Healthcare, an American manufacturer of diagnostic imaging solutions announced launching a new version of its robotic angiography systems, Allia IGS 7, which used artificial intelligence (AI) optimized imaging settings. A multiplicity of such new product launching is anticipated to accelerate the sales of robotic angiography systems in the North America market.

What is the Demand Outlook for Robotic Angiography Systems in the Europe Market?

Europe is expected to register growth at a steady CAGR in the global robotic angiography systems market during the forecast period 2022-2032, reveals Future Market Insights.

Over the past couple of years, there a swift increase in the incidence of cardiovascular diseases such as heart attack, arrhythmias, deep vein thrombosis, stroke, and others worldwide, due to the increasing smoking, tobacco & opioid use, alcohol abuse, and others.

As robotic angiography systems are used to visualize and identify narrow or blocked arteries, and malformed veins or arteries that result in limiting the blood flow to the heart, increasing prevalence of such ailments is projected to favor the growth in the Europe market.

Market Competition

Some of the key players in the robotic angiography systems market are GE Healthcare, KUKA AG, Philips Healthcare, Siemens Healthcare Private Limited, Corindus, Inc., Shimadzu Medical Systems, and others.

Attributed to the growing emphasis on introducing novel products and adopting strategies such as collaboration, agreement, and acquisition by leading companies, the market for robotic angiography systems is highly competitive.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 5% to 6% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015-2020
Forecast Period	2022-2032
Quantitative Units	Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Technology Application Indication End User Region
Countries Covered	North America Latin America Europe South Asia East Asia Oceania Middle East and Africa
Key Companies Profiled	GE Healthcare KUKA A Siemens Healthcare Private Limited Corindus, Inc. Philips Healthcare Shimadzu Medical Systems Others
Customization	Available Upon Request

Key Segments Profiled in the Robotic Angiography Systems Market Survey

By Technology:

• X-ray Angiography Systems
• CT Angiography Systems
• MR Angiography Systems

By Application:

• Coronary Angiography
• Endovascular Angiography
• Neuro-Angiography
• Onco-Angiography

By Indication:

• Coronary Artery Disease
• Valvular Heart Disease
• Congenital Heart Disease
• Congestive Heart Failure
• Others

By End User:

• Hospitals
• Specialty Clinics
• Diagnostic and Imaging Centers
• Academic and Research Institutes

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa